The high glucose microenvironment promotes tumor proliferation and inhibits autophagy and apoptosis by increasing the expression of SREBP1, and poor prognosis of the cancer patient is associated with elevated blood glucose levels in prostate cancer.39 This evidence concerns the gene SREBF1 and prostate cancer.